Literature DB >> 23475530

Combined non-invasive functional and anatomical diagnostic work-up in clinical practice: the magnetic resonance and computed tomography in suspected coronary artery disease (MARCC) study.

Jan G J Groothuis1, Aernout M Beek, Stijn L Brinckman, Martijn R Meijerink, Mijntje L P van den Oever, Mark B M Hofman, Cornelis van Kuijk, Albert C van Rossum.   

Abstract

AIMS: The combined use of cardiac computed tomography (CT) coronary angiography (CTCA) and myocardial perfusion imaging allows the non-invasive evaluation of coronary morphology and function. Cardiovascular magnetic resonance (CMR) imaging has several advantages: it can simultaneously assess myocardial perfusion, ventricular and valvular function, cardiomyopathy, and aortic disease and does not involve any additional ionizing radiation. We investigated the combined use of cardiac CT and CMR for the diagnostic evaluation of patients with suspected coronary artery disease (CAD) in clinical practice. METHODS AND
RESULTS: A total of 192 patients with low or intermediate pre-test probability of CAD underwent CTCA and CMR. All patients with obstructive CAD on CTCA and/or myocardial ischaemia on CMR were referred for invasive coronary angiography (ICA). Fractional flow reserve was measured in case of intermediate lesions (30-70% diameter stenosis) on ICA. Additional cardiac and extra-cardiac findings by CTCA and CMR were registered. The combination of CTCA and CMR significantly improved specificity and overall accuracy (94 and 91%) for the detection of significant CAD compared with their use as a single technique (CTCA 39 and 57%, P < 0.0001; CMR 82 and 83%, P = 0.016). No events were recorded during follow-up (18 ± 6 months) in 104 patients who did not undergo ICA. Furthermore, the combined strategy provided an alternative diagnosis in 19 patients.
CONCLUSION: The combined use of CTCA and CMR significantly improved specificity and overall diagnostic accuracy for the detection of significant CAD and allowed the detection of alternative (extra-)cardiac disease in patients without significant CAD.

Entities:  

Keywords:  Cardiac CT; Coronary artery disease; Magnetic resonance imaging

Mesh:

Year:  2013        PMID: 23475530     DOI: 10.1093/eurheartj/eht077

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Hybrid anatomo-functional imaging of coronary artery disease: Beneficial irrespective of its core components.

Authors:  Francesco Nudi; Giuseppe Biondi-Zoccai; Andrea Romagnoli; Orazio Schillaci; Alessandro Nudi; Francesco Versaci
Journal:  J Nucl Cardiol       Date:  2018-12-18       Impact factor: 5.952

2.  Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis.

Authors:  Asim Rizvi; Donghee Han; Ibrahim Danad; Bríain Ó Hartaigh; Ji Hyun Lee; Heidi Gransar; Wijnand J Stuijfzand; Hadi Mirhedayati Roudsari; Mahn Won Park; Jackie Szymonifka; Hyuk-Jae Chang; Erica C Jones; Paul Knaapen; Fay Y Lin; James K Min; Jessica M Peña
Journal:  JACC Cardiovasc Imaging       Date:  2017-08-16

3.  Anatomical versus functional assessment of coronary artery disease: direct comparison of computed tomography coronary angiography and magnetic resonance myocardial perfusion imaging in patients with intermediate pre-test probability.

Authors:  Marta Ponte; Nuno Bettencourt; Eulália Pereira; Nuno Dias Ferreira; Amedeo Chiribiri; Andreas Schuster; Aníbal Albuquerque; Vasco Gama; Eike Nagel
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-01       Impact factor: 2.357

Review 4.  Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2013-10       Impact factor: 5.952

Review 5.  2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.

Authors:  Yeonyee E Yoon; Yoo Jin Hong; Hyung-Kwan Kim; Jeong A Kim; Jin Oh Na; Dong Hyun Yang; Young Jin Kim; Eui-Young Choi
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

Review 6.  2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.

Authors:  Yeonyee E Yoon; Yoo Jin Hong; Hyung-Kwan Kim; Jeong A Kim; Jin Oh Na; Dong Hyun Yang; Young Jin Kim; Eui-Young Choi
Journal:  Korean Circ J       Date:  2014-11-25       Impact factor: 3.243

7.  Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial.

Authors:  Dominik Buckert; Simon Witzel; Maciej Cieslik; Raid Tibi; Wolfgang Rottbauer; Peter Bernhardt
Journal:  Trials       Date:  2017-07-28       Impact factor: 2.279

8.  Diagnostic Accuracy of Cardiac Magnetic Resonance Versus Fractional Flow Reserve: A Systematic Review and Meta-Analysis.

Authors:  Waqas Ullah; Sohaib Roomi; Hafez M Abdullah; Maryam Mukhtar; Zain Ali; Ping Ye; Donald C Haas; Vincent M Figueredo
Journal:  Cardiol Res       Date:  2020-05-03

9.  Danish study of Non-Invasive testing in Coronary Artery Disease (Dan-NICAD): study protocol for a randomised controlled trial.

Authors:  Louise Nissen; Simon Winther; Christin Isaksen; June Anita Ejlersen; Lau Brix; Grazina Urbonaviciene; Lars Frost; Lene Helleskov Madsen; Lars Lyhne Knudsen; Samuel Emil Schmidt; Niels Ramsing Holm; Michael Maeng; Mette Nyegaard; Hans Erik Bøtker; Morten Bøttcher
Journal:  Trials       Date:  2016-05-26       Impact factor: 2.279

10.  Comparison of the Diagnostic Accuracies of 1.5T and 3T Stress Myocardial Perfusion Cardiovascular Magnetic Resonance for Detecting Significant Coronary Artery Disease.

Authors:  Jee Young Min; Sung Min Ko; In Young Song; Jung Geun Yi; Hweung Kon Hwang; Je Kyoun Shin
Journal:  Korean J Radiol       Date:  2018-10-18       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.